We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+10.25%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.01%
AUM
$339B
AUM Growth
+$32.7B
Cap. Flow
+$7.03B
Cap. Flow %
2.08%
Top 10 Hldgs %
18.14%
Holding
3,647
New
148
Increased
2,572
Reduced
501
Closed
58

Sector Composition

Rank Sector Weight
1 Technology 21.96%
2 Financials 12.71%
3 Healthcare 11.98%
4 Consumer Discretionary 10.85%
5 Industrials 8.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NBEV
3251
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
$358K ﹤0.01%
346,853
+20,553
+6% +$27.1K
TSM icon
3252
TSMC
TSM
$2.1T
$355K ﹤0.01%
2,947
-42
-1% -$4.92K
TXMD icon
3253
TherapeuticsMD
TXMD
$23.5M
$355K ﹤0.01%
19,923
+902
+5% +$27K
ADN
3254
DELISTED
Advent Technologies
ADN
$351K ﹤0.01%
1,665
+118
+8% +$29.4K
CDRE icon
3255
Cadre Holdings
CDRE
$1.32B
$351K ﹤0.01%
+13,774
New +$280K
WVE icon
3256
Wave Life Sciences
WVE
$1.09B
$349K ﹤0.01%
111,120
+17,621
+19% +$73.2K
IMDX
3257
Insight Molecular Diagnostics
IMDX
$150M
$348K ﹤0.01%
8,009
ATCX
3258
DELISTED
Atlas Technical Consultants, Inc. Class A Common Stock
ATCX
$348K ﹤0.01%
41,301
+3,167
+8% +$30.4K
IMRX icon
3259
Immuneering
IMRX
$267M
$346K ﹤0.01%
21,397
+1,161
+6% +$28.3K
ITOT icon
3260
iShares Core S&P Total US Stock Market ETF
ITOT
$94.3B
$346K ﹤0.01%
3,225
+1,125
+54% +$118K
CRD.A icon
3261
Crawford & Co Class A
CRD.A
$532M
$344K ﹤0.01%
45,845
PPTA
3262
Perpetua Resources
PPTA
$2.3B
$335K ﹤0.01%
70,341
+13,535
+24% +$65.6K
CELC icon
3263
Celcuity
CELC
$4.21B
$334K ﹤0.01%
25,287
MEC icon
3264
Mayville Engineering Co
MEC
$654M
$334K ﹤0.01%
22,336
ATER icon
3265
Aterian
ATER
$4.45M
$332K ﹤0.01%
6,729
+1,251
+23% +$92.5K
GBL
3266
DELISTED
GAMCO Investors, Inc.
GBL
$329K ﹤0.01%
13,131
BRG
3267
DELISTED
Bluerock Residential Growth REIT, Inc.
BRG
$328K ﹤0.01%
12,401
-105,544
-89% -$1.68M
MBIO icon
3268
Mustang Bio
MBIO
$4.32M
$326K ﹤0.01%
261
+23
+10% +$37.1K
ETNB
3269
DELISTED
89bio
ETNB
$325K ﹤0.01%
24,809
BDTX icon
3270
Black Diamond Therapeutics
BDTX
$96.8M
$322K ﹤0.01%
60,313
AWH
3271
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
$322K ﹤0.01%
12,103
CRCT icon
3272
Cricut
CRCT
$984M
$318K ﹤0.01%
14,353
+5,000
+53% +$127K
SMED
3273
DELISTED
Sharps Compliance Corp
SMED
$317K ﹤0.01%
44,456
+9,216
+26% +$70.7K
ERNA icon
3274
Eterna Therapeutics
ERNA
$3.83M
$315K ﹤0.01%
10
XGN icon
3275
Exagen
XGN
$109M
$315K ﹤0.01%
27,074

Similar funds

Charles Schwab's Q4 2021 Portfolio in Review

As of Q4 2021, Charles Schwab held 3,647 positions worth $339B, up 11% from $306B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Charles Schwab's Q4 2021 filing shows 148 new, 2,572 increased, 501 reduced and 58 closed positions. Its largest new stake was Kyndryl: 2,951,149 shares worth $53.4M. The largest sale was State Street SPDR Portfolio Intermediate Term Corporate Bond ETF, an estimated $421M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.

  • Charles Schwab's largest Q4 2021 buy was Kyndryl: 2,951,149 shares worth $53.4M.
  • Charles Schwab added most to State Street SPDR Portfolio Short Term Treasury ETF in Q4 2021, an estimated $465M increase.
  • Charles Schwab's biggest Q4 2021 reduction was State Street SPDR Portfolio Intermediate Term Corporate Bond ETF, cutting an estimated $421M.
  • Charles Schwab fully exited Kansas City Southern in Q4 2021, selling an estimated $113M.
  • Charles Schwab's ten largest holdings make up 18% of its $339B portfolio in Q4 2021.
  • Charles Schwab opened 148 new positions and closed 58 in Q4 2021.
  • Charles Schwab's portfolio value rose 11% quarter-over-quarter to $339B.

Based on Charles Schwab's 13F filing for Q4 2021, filed 11 Feb 2022.